Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison Study of Combined ECT and Risperidone Versus ECT Alone for Treatment Resistant Depression.

NCT00203723 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00203723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison Study of Combined ECT and Risperidone Versus ECT Alone for Treatment Resistant Depression.
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Terminated
Start date
March 31, 2005
Completion date
May 31, 2006
Enrollment
45
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depression